Deltex grows production capacity:
This article was originally published in Clinica
UK haemodynamic monitoring company Deltex Medical is to raise around £1.9m ($3.8m) through the sale of over eight million new shares. The firm said it will use the proceeds to significantly expand its manufacturing capability in response to the sales growth following the start of US reimbursement coverage of its CardioQ haemodynamic monitoring system at the end of May. Deltex plans to more than double its existing production capacity, automate certain processes in the manufacture of its disposable probes, further improve the functionality of its CardioQ monitor, and continue to broaden its IP position.